www.fool.com
Open in
urlscan Pro
104.18.24.135
Public Scan
URL:
https://www.fool.com/investing/2023/04/25/medtronic-partnering-with-nvidia-is-it-a-buy/
Submission: On April 26 via manual from GB — Scanned from GB
Submission: On April 26 via manual from GB — Scanned from GB
Form analysis
0 forms found in the DOMText Content
Skip to main contentEnable accessibility for visually impairedOpen the accessibility menu Open the Accessible Navigation Menu Search Log In Help Join The Motley Fool Our Services Investing Basics angle-down Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 118% Rule Breakers High-growth Stocks Return 208% S&P Return 100% Returns as of 04/26/2023 View Our Services Investing 101 * How to Invest Money * What to Invest In * How to Invest in Stocks * How to Invest in Index Funds * How to Invest in ETFs * How to Invest in Real Estate * Financial Dictionary Best Accounts * Best Stock Brokers * Best Brokers for Beginners * Best IRA Accounts * Best Roth IRA Accounts * Best Options Brokers * Best Crypto Apps Stock Market Basics * Stock Market 101 * Types of Stocks * Stock Market Sectors * Stock Market Indexes * S&P 500 * Dow Jones * Nasdaq Composite Stock Market angle-down Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 118% Rule Breakers High-growth Stocks Return 208% S&P Return 100% Returns as of 04/26/2023 View Our Services Stocks * Growth Stocks * Value Stocks * Dividend Stocks * Small Cap Stocks * Large Cap Stocks * Blue Chip Stocks * How to Buy Stocks Industries to Invest In * Consumer Goods * Technology * Energy * Healthcare * Financial * Cryptocurrency * NFTs News * Top Stocks to Buy in 2023 * Stock Market News Retirement angle-down Getting Started * Retirement 101 * Why to Start Saving Now * Types of Retirement Accounts * 401k Basics * IRA Basics * HSA Basics Planning for Retirement * How Much Do I Need to Retire? * When To Retire * Factoring in Social Security * What is the Full Retirement Age? * Investing for Retirement * Retirement Strategies Retired: What Now? * Retiring in 2023 * Withdrawal Strategies * Healthcare in Retirement * Taxes in Retirement * Estate Planning Personal Finance angle-down Credit Cards * Best Credit Cards * Best Cash Back Cards * Best Balance Transfer Cards * Best Travel Credit Cards * Best 0% Credit Cards * Best Rewards Cards * Best Cards for Bad Credit Bank & Loans * Best Savings Accounts * Best Checking Accounts * Best CD Rates * Best Personal Loans * Best Debt Consolidation Loans Homebuying * Best Mortgage Lenders * Best Mortgage Refi Lenders * Best Lenders for First-time Buyers * Best FHA Mortgage Lenders * Current Mortgage Rates Guides * Credit Cards 101 * Bank Accounts 101 * Home Loans 101 * Pay Off Debt * Increase Your Credit Score About Us angle-down Our Purpose: To make the world smarter, happier, and richer. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Who Is the Motley Fool? * About Us * Investing Philosophy * Reviews * The Motley Fool Foundation * Newsroom * Contact Us * Publishing Standards Fool Podcasts * Podcasts Home * Motley Fool Money * Rule Breaker Investing Social Media * Facebook * Twitter * YouTube * Discussion Boards * CAPS - Stock Picking Community Other Services * The Ascent Latest Stock Picks Bars Times Search * Our Services * Investing Basics angle-down angle-up Investing 101 * How to Invest Money * What to Invest In * How to Invest in Stocks * How to Invest in Index Funds * How to Invest in ETFs * How to Invest in Real Estate * Financial Dictionary Best Accounts * Best Stock Brokers * Best Brokers for Beginners * Best IRA Accounts * Best Roth IRA Accounts * Best Options Brokers * Best Crypto Apps Stock Market Basics * Stock Market 101 * Types of Stocks * Stock Market Sectors * Stock Market Indexes * S&P 500 * Dow Jones * Nasdaq Composite Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 118% Rule Breakers High-growth Stocks Return 208% S&P Return 100% Returns as of 04/26/2023 View Our Services * Stock Market angle-down angle-up Stocks * Growth Stocks * Value Stocks * Dividend Stocks * Small Cap Stocks * Large Cap Stocks * Blue Chip Stocks * How to Buy Stocks Industries to Invest In * Consumer Goods * Technology * Energy * Healthcare * Financial * Cryptocurrency * NFTs News * Top Stocks to Buy in 2023 * Stock Market News Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 118% Rule Breakers High-growth Stocks Return 208% S&P Return 100% Returns as of 04/26/2023 View Our Services * Retirement angle-down angle-up Getting Started * Retirement 101 * Why to Start Saving Now * Types of Retirement Accounts * 401k Basics * IRA Basics * HSA Basics Planning for Retirement * How Much Do I Need to Retire? * When To Retire * Factoring in Social Security * What is the Full Retirement Age? * Investing for Retirement * Retirement Strategies Retired: What Now? * Retiring in 2023 * Withdrawal Strategies * Healthcare in Retirement * Taxes in Retirement * Estate Planning * Personal Finance angle-down angle-up Credit Cards * Best Credit Cards * Best Cash Back Cards * Best Balance Transfer Cards * Best Travel Credit Cards * Best 0% Credit Cards * Best Rewards Cards * Best Cards for Bad Credit Bank & Loans * Best Savings Accounts * Best Checking Accounts * Best CD Rates * Best Personal Loans * Best Debt Consolidation Loans Homebuying * Best Mortgage Lenders * Best Mortgage Refi Lenders * Best Lenders for First-time Buyers * Best FHA Mortgage Lenders * Current Mortgage Rates Guides * Credit Cards 101 * Bank Accounts 101 * Home Loans 101 * Pay Off Debt * Increase Your Credit Score * About Us angle-down angle-up Who Is the Motley Fool? * About Us * Investing Philosophy * Reviews * The Motley Fool Foundation * Newsroom * Contact Us * Publishing Standards Fool Podcasts * Podcasts Home * Motley Fool Money * Rule Breaker Investing Social Media * Facebook * Twitter * YouTube * Discussion Boards * CAPS - Stock Picking Community Other Services * The Ascent Our Purpose: To make the world smarter, happier, and richer. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. * Log In * Help * Join The Motley Fool Latest Stock Picks Free Article Join Our Premium Members And Get More In-Depth Stock Guidance and Research MEDTRONIC IS PARTNERING WITH NVIDIA TO CREATE POTENTIALLY GAME-CHANGING TECH. IS THE STOCK A BUY? By Adria Cimino – Apr 25, 2023 at 1:14PM KEY POINTS * Medtronic will use Nvidia AI technology to detect precancerous tissue earlier -- and improve patient outcomes. * The medical device giant sees AI as the key to personalized medicine. * 10 stocks we like better than Medtronic Plc NYSE: MDT MEDTRONIC PLC Market Cap Today's Change Arrow-Thin-Down (%) Current Price $89.69 Price as of April 25, 2023, 3:00 p.m. ET You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More MEDTRONIC MAY BE AMONG THE COMPANIES TO DOMINATE THE AI HEALTHCARE MARKET. Medtronic (MDT) is not new to innovation. The medical device giant sells a broad range of cutting-edge products, such as the Hugo robotic surgery system and the world's first insulin pump featuring meal detection technology to regulate insulin levels. Medtronic's products are used worldwide to address more than 70 health problems. This portfolio has brought the device maker billions of dollars in revenue and profit. But the company's growth may not have reached its maximum. In fact, one particular thing might spur a new wave of growth at Medtronic. The company recently partnered with Nvidia on an artificial intelligence (AI) project -- and it could be a game changer for doctors, patients, and the company. Does this make Medtronic stock a buy? Let's find out. MEDTRONIC AND AI First, a little background on Medtronic and AI. Medtronic has been exploring and using AI for some time. In fact, its work in the area is already bearing fruit. For example, it's the only company that has scored U.S. Food and Drug Administration (FDA) clearance for spine surgery predictive models. Last year, the company won regulatory clearance for its UNiD spine analyzer 4.0 platform -- a massive surgical database that powers algorithms to help surgeons better predict eventual spinal alignment. AI allows surgeons to visualize the most likely outcomes for a particular patient, and that helps them better plan their procedures. AI "is the key to unlocking a new level of personalized medicine in the 21st century," Bob White, executive vice president of Medtronic's medical surgical portfolio, is quoted as saying on the company's website. The company has even defined a "AI compass," a list of guiding principles for the company to use when applying AI to healthcare. So it's fair to say Medtronic is going all-in on AI. Let's move on to the latest news. Medtronic is already using its AI tool GI Genius to detect polyps that may lead to colorectal cancer. Now Medtronic is planning to integrate Nvidia Holoscan and Nvidia IGX to further help doctors identify precancerous tissue using "AI-enhanced" diagnostic images. The partnership also aims to create a broad platform of AI that can progressively improve diagnostics and result in better outcomes. The idea is that third-party developers will be able to create AI tools that may be distributed through GI Genius. A third partner, Cosmo Pharmaceuticals, is running an innovation center website, allowing developers to build and test potential AI software that may one day become part of the GI Genius platform. This is exciting because Medtronic may benefit from its own technology and that of Nvidia -- and because outside talent may eventually contribute to GI Genius. "The possibility for GI Genius to host multiple real-time AI applications is a game changer," said Giovanni Di Napoli, president of Medtronic's gastrointestinal business, in a press release. Arrows-In Collapse NYSE: MDT Medtronic Plc Today's Change (%) $0.00 Current Price $89.69 Arrow-Thin-Down YTD1w1m3m6m1y 5y +10.33% Price VS S&P MDT KEY DATA POINTS Market Cap Day's Range $89.43 - $91.00 52wk Range $75.77 - $108.25 Volume 3,910 Avg Vol Gross Margin 0.00% Dividend Yield N/A A GROWING AI HEALTHCARE MARKET It's also important to keep in mind that the global market for AI in healthcare is forecast to expand at a compound annual growth rate of more than 37% from next year through 2030, according to Grand View Research. Those who establish themselves as leaders have a lot to gain. Medtronic is among the top five medical device companies worldwide poised to dominate in the AI healthcare world, according to research company GlobalData. Still, competition may be tough. That top five includes other heavyweights, like Johnson & Johnson, which spent almost $15 billion on research and development (R&D) last year. We don't have full-year results for Medtronic yet, but in the first nine months of the fiscal year, the company spent about $2 billion on R&D. So J&J has the resources to take the lead, but that won't necessarily weigh on Medtronic as more than one player may benefit from an AI revolution. EARNINGS AND GROWTH Does this AI deal with Nvidia make Medtronic a buy? The efforts in AI are a big plus, but I wouldn't buy Medtronic for its AI efforts only. I would consider the company's general earnings picture and growth prospects as well. And in these areas, you'll find more reasons to like Medtronic. The company has increased earnings over time. MDT Net Income (Annual) data by YCharts Today it's streamlining its portfolio by spinning off its patient monitoring and respiratory interventions businesses. It's completed acquisitions that should boost growth -- like that of Affera, which strengthens its cardiac ablation portfolio. And over the past year, Medtronic has won more than 150 product approvals in major geographies. Medtronic also puts a focus on R&D investment, targeting growth at or above revenue growth. So what do investors have to pay for all of this? MDT PE Ratio data by YCharts Medtronic trades for 29 times trailing-12-month earnings. That's around its lowest levels over the past decade. This looks dirt cheap. That's because Medtronic's focus on AI -- and its new products and efforts right now -- should lead to solid long-term growth. That makes this top healthcare stock a buy today, one that could deliver big over time. SHOULD YOU INVEST $1,000 IN MEDTRONIC PLC RIGHT NOW? Before you consider Medtronic Plc, you'll want to hear this. The Motley Fool Stock Advisor analyst team just revealed what they believe are the 10 best stocks for investors to buy right now... and Medtronic Plc wasn't one of them. Stock Advisor is the online investing service that has beaten the stock market by 3x since 2002*. And right now, they think there are 10 stocks that are better buys. See the 10 stocks *Stock Advisor returns as of April 24, 2023 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy. 5 Stocks Under $49 We hear it over and over from investors, “I wish I had bought Amazon or Netflix when they were first recommended by the Motley Fool. I’d be sitting on a gold mine!” And it’s true. And while Amazon and Netflix have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $49 a share! You can grab a copy of “5 Growth Stocks Under $49” for FREE for a limited time only. Click here to learn more. Learn more INVEST SMARTER WITH THE MOTLEY FOOL JOIN OUR PREMIUM MEMBERS RECEIVING… * New Stock Picks Each Month * Detailed Analysis of Companies * Model Portfolios * Live Streaming During Market Hours * And Much More Get Started Now STOCKS MENTIONED Medtronic Plc MDT $89.69 (%) MOTLEY FOOL STOCK ADVISOR'S LATEST PICK Get Access 395% Avg Return* Nvidia NVDA $262.41 (-2.96%) $-8.01 *Average returns of all recommendations since inception. Cost basis and return based on previous market day close. RELATED ARTICLES Why Medtronic Stock Edged Higher Today Why Medtronic Stock Soared More Than 4% Higher Today If You Invested $10,000 in Medtronic in 2013, This Is How Much You Would Have Today 2 Top Healthcare Stocks to Buy Right Now 2 Dividend Growth Stalwarts With Impressive Streaks Going and Yield Twice That of the S&P 500 395% MOTLEY FOOL RETURNS Market-beating stocks from our flagship service. Stock Advisor Returns 395% S&P 500 Returns 118% Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/26/2023. Discounted offers are only available to new members. Stock Advisor list price is $199 per year. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns. OUR MOST POPULAR ARTICLES 3 No-Brainer Stocks to Buy With $300 Right Now For Only the 4th Time in 63 Years, This Economic Indicator Offers an Ominous Warning for Wall Street The Fed Says a Recession Is Coming: History Says the Stock Market Will Do This Next 3 Unstoppable Stocks That Can Safely Turn $325,000 Into $1 Million by 2033 PREMIUM INVESTING SERVICES Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services Making the world smarter, happier, and richer. * Facebook Facebook * Twitter Twitter * Linked In LinkedIn * Pinterest Pinterest * YouTube YouTube * Instagram Instagram * Tiktok TikTok © 1995 - 2023 The Motley Fool. All rights reserved. Market data powered by Xignite. ABOUT THE MOTLEY FOOL * About Us * Careers * Research * Newsroom * Contact * Advertise OUR SERVICES * Stock Advisor * Rule Breakers * Rule Your Retirement * The Ascent * All Services AROUND THE GLOBE * Fool UK * Fool Australia * Fool Canada FREE TOOLS * CAPS Stock Ratings * Discussion Boards * Calculators * Financial Dictionary OUR AFFILIATES * Motley Fool Asset Management * Motley Fool Wealth Management * Motley Fool Ventures * Lakehouse Capital * 1623 Capital * Terms of Use * Privacy Policy * Disclosure Policy * Accessibility Policy * Copyright, Trademark and Patent Information * Terms and Conditions * Do Not Sell My Personal Information Current This website uses cookies to deliver our services and to analyze traffic. We also share information about your use of our site with advertising and other partners. Privacy Policy Got it Cookie Settings